Lung Cancer Considered

In this special edition of Lung Cancer Considered, three oncologists and lung cancer experts explore lung cancer in the Middle East (North Africa), spoken in Arabic. Host Dr. Nagla Karim, MD, PHD, Di...

12 Joulu 202231min

This episode of Lung Cancer Considered covers a subset of patients with non-small cell lung cancer with lung cancer -- MET exon 14 skipping mutations. MET exon 14 skipping mutations occur in approxima...

6 Joulu 202246min

This episode of Lung Cancer Considered is part of our series on FDA approvals of new lung cancer therapies. Today, host Dr. Stephen Liu discusses the EMPOWER-Lung 3 regimen of the PD-1 inhibitor cemip...

29 Marras 202240min

Dr. Narjust Florez discusses the POSEIDON trial with guest Dr. Tejas Patil, assistant professor at Thoracic Oncology Research Initiative, University of Colorado Cancer Center. This Phase III study led...

28 Marras 202233min

In this episode of Lung Cancer Considered, host Dr. Stephen Liu, Director of Thoracic Oncology at Georgetown University, leads a discussion about the management of stage III NSCLC. Joining him are ...

15 Marras 202253min

There has been a steady stream of research presented that ties air pollution to an increased risk for lung cancer. To discuss this trend, Lung Cancer Considered host Dr. Narjust Florez interviews Dr. ...

15 Marras 202240min

At the time it was published in the New England Journal of Medicine in 2002, ECOG 1594 was the first study to compare whether any of the three chemotherapy regimens used at the time was superior to ci...

8 Marras 202236min

Lung cancer research is often centered at large, urban academic medical centers. But what research and treatment options are available for those patients with lung cancer who live in rural areas? In...

1 Marras 202243min